E. Graham

Efficacy of an Ondansetron Orally Disintegrating Tablet: A Novel Oral Formulation of this 5-HT3 Receptor Antagonist in the Treatment of Fractionated Radiotherapy-Induced Nausea and Emesis

L. Goedhals, L. Souhami, P. Feyer, 1999 .

Centipede Envenomations: Clinical Effects and Treatment

R. Vohra, N. Brandehoff, E. Graham, 2014 .

A MULTICENTER, DOUBLE-BLIND COMPARISON OF I.V. AND ORAL ADMINISTRATION OF ONDANSETRON PLUS DEXAMETHASONE FOR ACUTE CISPLATIN-INDUCED EMESIS

M. Krzakowski, F. Joly, L. Yelle, 1998 .

A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis. Ondansetron Acute Emesis Study Group.

M. Krzakowski, F. Joly, L. Yelle, 1998, Anti-cancer drugs.

Challenges of antiretroviral treatment in transient and drug-using populations: the SUN study.

C. Farthing, M. Sension, R. Pilson, 2001, AIDS patient care and STDs.

Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment.

L. Goedhals, L. Souhami, P. Feyer, 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).